Reshma Rangwala insider trades

Open-market stock purchases and sales by Reshma Rangwala, EVP & Chief Medical Officer at Karyopharm Therapeutics Inc, from SEC Form 4 filings since Sep 28, 2020.

Recent trades

DateStockTradeValue
May 14, 2026KPTI Karyopharm Therapeutics IncSold$3.9K
May 13, 2026KPTI Karyopharm Therapeutics IncBought (not open market)—
Apr 21, 2026KPTI Karyopharm Therapeutics IncSold$4K
Mar 2, 2026KPTI Karyopharm Therapeutics IncSold$47.7K
Jan 31, 2026KPTI Karyopharm Therapeutics IncBought (not open market)—

Companies traded

  • KPTI Karyopharm Therapeutics Inc: 11 sales, last May 14, 2026
  • ARAV Aravive, Inc: other filings, last Jan 24, 2022

Get free alerts when Reshma Rangwala files a new trade →